Magnetic resonance imaging of focal and diffuse hepatic disease

Seminars in Ultrasound CT and MRI

Volumn 19, Issue 1, 1998, Pages 2-34

  Siegelman, Evan S ^a   Outwater, Eric K ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; FATTY LIVER; HEPATITIS; HUMAN; IRON OVERLOAD; LIVER ABSCESS; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER CYST; LIVER DISEASE; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER POLYCYSTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 0031892862     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2171(98)90022-1     Document Type: Review

References (312)

1. Siegelman ES, Outwater EK: Magnetic resonance imaging techniques of the liver. Radiol Clin North Am 36:263-286, 1998
2. Soyer P, Bluemke DA, Rymer R: MR imaging of the liver: Technique. Magn Reson Imaging Clin North Am 5:205-221, 1997
3. Sami S, Nelson RC: Technique for MR imaging of the liver. Radiology 197:575-577, 1995
4. Mahfouz A, Hamm B: Contrast agents. Magn Reson Imaging Clin North Am 5:223-240, 1997
5. Low RN: Contrast agents for MR imaging of the liver. J Magn Reson Imaging 7:56-57, 1997
6. Van Beers BE, Gallez B, Pringot J: Contrast-enhanced MR imaging of the liver. Radiology 203:297-306, 1997
7. Itai Y, Ohtomo K, Furui S, et al: Noninvasive diagnosis ofsmall cavernous hemangioma of the liver: Advantage of MRI. AJR Am J Roentgenol 145:1195-1199, 1985
8. Powers C, Ros PR, Stoupis C, et al: Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 14:459-482, 1994
9. Vassiliades VG, Bree RL, Korobkin M: Focal and diffuse benign hepatic disease: Correlative imaging. Semin Ultrasound CT MR 13:313-335, 1992
10. Karhunen PJ: Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39:183-188, 1986
11. Tung GA, Cronan JJ: Percutaneous needle biopsy of hepatic cavernous hemangioma. J Clin Gastroenterol 16:117-122, 1993
12. Yamashita Y, Ogata I, Urata J, Takahashi M: Cavernous hemangioma of the liver: Pathologic correlation with dynamic CT findings. Radiology 203:121-125, 1997
13. Semelka RC, Mitchell DG: Liver and biliary system, in Edelman RR, Hesselink JR, Zlatkin MB (eds): Clinical Magnetic Resonance Imaging. Philadelphia, PA, Saunders, vol 2, 1996, pp 1466-1512
14. Powers C, Ros PR: Hepatic mass lesions, in Haaga JR, Lanzieri CF, Sartoris DJ, Zerhouni EA (eds): Computed Tomography and Magnetic Resonance Imaging of the Whole Body. Philadelphia, PA, vol 2, Saunders, 1994, pp 896-944
15. Manfredi R, Maresca G, De Gaetano AM, et al: [The tissue characterization of focal liver lesions with magnetic resonance imaging]. Radiol Med (Torino) 90:250-261, 1995
16. Ohtomo K, Itai Y, Yoshikawa K, et al: Hepatocellular carcinoma and cavernous hemangioma: Differentiation with MR imaging. Efficacy of T2 values at 0.35 and 1.5 T. Radiology 168:621-623, 1988
17. Brown JJ, Lee JM, Lee JK, et al: Focal hepatic lesions: Differentiation with MR imaging at 0.5 T. Radiology 179:675-679, 1991
18. Mirowitz SA, Lee JK, Heiken JP: Cavernous hemangioma of the liver: Assessment of MR tissue specificity with a simplified T2 index. J Comput Assist Tomogr 14:223-228, 1990
19. Ohtomo K, Itai Y, Furui S, et al: Hepatic tumors: Differentiation by transverse relaxation time (T2) of magnetic resonance imaging. Radiology 155:421-423, 1985
20. Egglin TK, Rummeny E, Stark DD, et al: Hepatic tumors: Quantitative tissue characterization with MR imaging. Radiology 176:107-110, 1990
21. Stark DD, Felder RC, Wittenberg J, et al: Magnetic resonance imaging of cavernous hemangioma of the liver: Tissue-specific characterization. AJR Am J Roentgenol 145:213-222, 1985
22. Wittenberg J, Stark DD, Forman BH, et al: Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR Am J Roentgenol 151:79-84, 1988
23. Berger JF, Laissy JP, Limot O, et al: Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: Value of enhanced MRI. J Comput Assist Tomogr 20:349-355, 1996
24. Itoh K, Saini S, Hahn PF, et al: Differentiation between small hepatic hemangiomas and metastases on MR images: Importance of size-specific quantitative criteria. AJR Am J Roentgenol 155:61-66, 1990
25. Lee MG, Baker ME, Sostman HD, et al: The diagnostic accuracy/efficacy of MRI in differentiating hepatic hemangiomas from metastatic colorectal/breast carcinoma: A multiple reader ROC analysis using a jackknife technique. J Comput Assist Tomogr 20:905-913, 1996
26. Ohtomo K, Itai Y, Yoshida H, et al: MR differentiation of hepatocellular carcinoma from cavernous hemangioma: Complementary roles of FLASH and T2 values. AJR Am J Roentgenol 152:505-507, 1989
27. Soyer P, Dufresne AC, Somveille E, Scherrer A: Hepatic cavernous hemangioma: Appearance on T2-weighted fast spinecho MR imaging with and without fat suppression. AJR 168:461-465, 1997
28. Soyer P, Gueye C, Somveille E, et al: MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: Relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images. AJR Am J Roentgenol 165:1407-1413, 1995
29. Whitney WS, Herfkens RJ, Jeffrey RB, et al: Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 189:863-870, 1993
30. Semelka RC, Brown ED, Ascher SM, et al: Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192:401-406, 1994
31. Jelinek J: Imaging of liver hemangiomas. AJR Am J Roentgenol 166:459, 1996
32. Tung GA, Vaccaro JP, Cronan JJ, Rogg JM: Cavernous hemangioma of the liver: Pathologic correlation with high-field MR imaging [see comments]. AJR Am J Roentgenol 162:1113-1117, 1994
33. Birnbaum BA, Weinreb JC, Megibow AJ, et al: Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology 176:95-101, 1990
34. Hamm B, Fischer E, Taupitz M: Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. J Comput Assist Tomogr 14:205-216, 1990
35. Lombardo DM, Baker ME, Spritzer CE, et al: Hepatic hemangiomas vs metastases: MR differentiation at 1.5 T. AJR Am J Roentgenol 155:55-59, 1990
36. Li KC, Glazer GM, Quint LE, et al: Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology 169:409-415, 1988
37. Ito K, Choji T, Nakada T, et al: Multislice dynamic MRI of hepatic tumors. J Comput Assist Tomogr 17:390-396, 1993
38. Mitchell DG, Saini S, Weinreb J, et al: Hepatic metastases and cavernous hemangiomas: Distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193: 49-57, 1994
39. Yoshida H, Itai Y, Ohtomo K, et al: Small hepatocellular carcinoma and cavernous hemangioma: Differentiation with dynamic FLASH MR imaging with Gd-DTPA. Radiology 171:339-342, 1989
40. Olivetti L, Grazioli L, Maroldi R, et al: [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]. Radiol Med (Torino) 83:353-360, 1992
41. Ohtomo K, Itai Y. Yoshikawa K, et al: Hepatic haemangioma: Dynamic MRI using gadolinium-DTPA. Eur J Radiol 7:257-259, 1987
42. Abbas YA, Kressel HY, Wehrli FW, et al: Differential diagnosis of hepatic neoplasms: Spin echo versus gadolinium-diethylenetriaminepentaacetate-enhanced gradient echo imaging. Magn Reson Q 7:275-292, 1991
43. Okada Y, Itai Y, Ohtomo K, et al: MR differentiation of hepatic haemangioma and hepatocellular carcinoma: Value of delayed-phase Gd-DTPA enhanced images. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 154:621-627, 1991
44. Urhahn R, Kilbinger M, Drobnitzky M, et al: Dynamic Gd-enhanced MR imaging of hepatic hemangioma: Is high temporal resolution requisite for characterization? Magn Reson Imaging 14:31-41, 1996
45. Outwater EK, Ito K, Siegelman ES, et al: Rapidly enhancing hepatic hemangiomas at MR imaging: Distinction from malignancies with T2-weighted images. J Magn Reson Imaging 7:1033-1039, 1997
46. Ros PR, Lubbers PR, Olmsted WW, Morillo G: Hemangioma of the liver: Heterogeneous appearance on T2-weighted images. AJR Am J Roentgenol 149:1167-1170, 1987
47. Takayasu K, Moriyama N, Shima Y, et al: Atypical radiographic findings in hepatic cavernous hemangioma: Correlation with histologic features. AJR Am J Roentgenol 146:1149-1153, 1986
48. Cheng HC, Tsai SH, Chiang JH, Chang CY: Hyalinized liver hemangioma mimicking malignant tumor at MR imaging [letter; comment]. AJR Am J Roentgenol 165:1016-1017, 1995
49. Mathieu D, Rahmouni A, Vasile N, et al: Sclerosed liver hemangioma mimicking malignant tumor at MR imaging: Pathologic correlation. J Magn Reson Imaging 4:506-508, 1994
50. Gaines PA, Sampson MA: The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol 62:335-337, 1989
51. Forbes A, Murray-Lyon IM: Cystic disease of the liver and biliary tract. Gut 32:166-122, 1991
52. McFarland EG, Mayo-Smith WW, Saini S, et al: Hepatic hemangiomas and malignant tumors: Improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 193:43-47, 1994
53. Li W, Nissenbaum MA, Stehling MK, et al: Differentiation between hemangiomas and cysts of the liver with nonenhanced MR imaging: Efficacy of T2 values at 1.5 T. J Magn Reson Imaging 3:800-802, 1993
54. Ito K, Mitchell DG, Outwater RK, et al: Hepatic lesions: Discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 204:729-737, 1997
55. Bryan DH, Pillarisetty S: Cyst of the falciform ligament of the liver: A rare cause of right upper quadrant pain. Am Surg 58:779-781, 1992
56. Ibrarullah, Agarwal DK, Baijal WA, et al: Solitary non-parasitic cysts of the liver: Presentation and management. Trop Gastroenterol 14:68-72, 1993
57. Schwartz JH, Ellison EC: Focal liver lesions. Evaluation of simple and complex cysts. Postgrad Med 95:149-152, 1994
58. Terada N, Shimizu T, Imai Y, et al: Benign, non-parasitic hepatic cyst causing obstructive jaundice. Intern Med 32:857-860, 1993
59. Morino M, De Giuli M, Festa V, Garrone C: Laparoscopic management of symptomatic nonparasitic cysts of the liver. Indications and results. Ann Surg 219:157-164, 1994
60. Nelson J, Davidson D, McKittrick JE: Simple surgical treatment of nonparasitic hepatic cysts. Am Surg 58:755-757, 1992
61. Sanchez H, Gagner M, Rossi RL, et al: Surgical management of nonparasitic cystic liver disease. Am J Surg 161:113-118; discussion 118-119, 1991
62. Levine E, Cook LT, Grantham JJ: Liver cysts in autosomal-dominant polycystic kidney disease: Clinical and computed tomographic study. AJR Am J Roentgenol 145:229-233, 1985
63. Thomsen HS, Thaysen JH: Frequency of hepatic cysts in adult polycystic kidney disease. Acta Med Scand 224:381-384, 1988
64. Itai Y, Ebihara R, Eguchi N, et al: Hepatobiliary cysts in patients with autosomal dominant polycystic kidney disease: Prevalence and CT findings. AJR Am J Roentgenol 164:339-342, 1995
65. Kida T, Nakanuma Y, Terada T: Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: An autopsy study. Hepatology 16:334-340, 1992
66. Redston MS, Wanless IR: The hepatic von Meyenburg complex with hepatic and renal cysts. Mod Pathol 9:233-237, 1996
67. Gladziwa U, Bohm R, Malms J, et al: Diagnosis and treatment of a solitary infected hepatic cyst in two patients with adult polycystic kidney disease. Clin Nephrol 40:205-207, 1993
68. Telenti A, Torres VE, Gross JB, Jr., et al: Hepatic cyst infection in autosomal dominant polycystic kidney disease [see comments]. Mayo Clin Proc 65:933-942, 1990
69. Dumot JA, Fields MS, Meyer RA, et al: Alcohol sclerosis for polycystic liver disease and obstructive jaundice: Use of a nasobiliary catheter. Am J Gastroenterol 89:1555-1557, 1994
70. Vauthey JN, Maddern GJ, Kolbinger P, et al: Clinical experience with adult polycystic liver disease. Br J Surg 79:562-565, 1992
71. Starzl TE, Reyes J, Tzakis A, et al: Liver transplantation for polycystic liver disease. Arch Surg 125:575-577, 1990
72. Bradley WG, Jr: MR appearance of hemorrhage in the brain [see comments]. Radiology 189:15-26, 1993
73. Vilgrain V, Silbermann O, Benhamou JP, Nahum H: MR imaging in intracystic hemorrhage of simple hepatic cysts. Abdom Imaging 18:164-167, 1993
74. Davis PL, Kanal E, Farnum GN, et al: MR imaging of multiple hepatic cysts in a patient with polycystic liver disease. Magn Reson Imaging 5:407-411, 1987
75. Wilcox DM, Weinreb JC, Lesh P: MR imaging of a hemorrhagic hepatic cyst in a patient with polycystic liver disease. J Comput Assist Tomogr 9:183-185, 1985
76. Terada T, Nakanuma Y: Pathological observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. III. Survey of necroinflammation and cystic dilatation. Hepatology 12:1229-1233, 1990
77. Nakanuma Y, Kurumaya H, Ohta G: Multiple cysts in the hepatic hilum and their pathogenesis. A suggestion of periductal gland origin. Virchows Arch A Pathol Anat Histopathol 404:341-350, 1984
78. Hoshiba K, Matsui O, Kadoya M, et al: Peribiliary cysts in cirrhotic liver: observation on computed tomography. Abdom Imaging 21:228-232, 1996
79. Baron RL, Campbell WL, Dodd GDr: Peribiliary cysts associated with severe liver disease: Imaging-pathologic correlation. AJR Am J Roentgenol 162:631-636, 1994
80. Itai Y, Ebihara R, Tohno E, et al: Hepatic peribiliary cysts: Multiple tiny cysts within the larger portal tract, hepatic hilum, or both. Radiology 191:107-110, 1994
81. Terada T, Minato H, Nakanuma Y, et al: Ultrasound visualization of hepatic peribiliary cysts: A comparison with morphology. Am J Gastroenterol 87:1499-1502, 1992
82. Terayama N, Matsui O, Hoshiba K, et al: Peribiliary cysts in liver cirrhosis: US, CT, and MR findings. J Comput Assist Tomogr 19:419-423, 1995
83. Wanless IR, Zahradnik J, Heathcote EJ: Hepatic cysts of periductal gland origin presenting as obstructive jaundice. Gastroenterology 93:894-898, 1987
84. Wanless IR, Heathcote EJ: Two cases of obstructive jaundice secondary to hamartomatous cystic changes in the bile ducts [letter]. Hum Pathol 20:399-400, 1989
85. Mendez RJ, Schiebler ML, Outwater EK, Kressel HY: Hepatic abscesses: MR imaging findings. Radiology 190:431-436, 1994
86. Runge VM, Kirsch JE, Woolfolk C, et al: Gadoteridol dose dependence in MR imaging of a liver abscess model. J Magn Reson Imaging 4:343-350, 1994
87. Runge VM, Wells JW, Williams NM: Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA. Invest Radiol 31:781-788, 1996
88. Weissleder R, Saini S, Stark DD, et al: Pyogenic liver abscess: Contrast-enhanced MR imaging in rats. AJR Am J Roentgenol 150:115-120, 1988
89. Schmiedl U, Paajanen H, Arakawa M, et al: MR imaging of liver abscesses; application of Gd-DTPA. Magn Reson Imaging 6:9-16, 1988
90. Jeffrey RB, Jr., Tolentino CS, Chang FC, et al: CT of small pyogenic hepatic abscesses: The cluster sign [see comments]. AJR Am J Roentgenol 151:487-489, 1988
91. Anttila VJ, Ruutu P, Bondestam S, et al: Hepatosplenic yeast infection in patients with acute leukemia: A diagnostic problem. Clin Infect Dis 18:979-981, 1994
92. Anttila VJ, Elonen E, Nordling S, et al: Hepatosplenic candidiasis in patients with acute leukemia: Incidence and prognostic implications. Clin Infect Dis 24:375-380, 1997
93. Fenaux P, Lemaitre L, Ajana F, et al: Hepatosplenic candidiasis: An overlooked cause of prolonged fever during recovery from an episode of neutropenia. Nouv Rev Fr Hematol 31:45-49, 1989
94. Rossetti F, Brawner DL, Bowden R, et al: Fungal liver infection in marrow transplant recipients: Prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis 20:801-811, 1995
95. Thaler M, Pastakia B, Shawker TH, et al: Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Ann Intern Med 108:88-100, 1988
96. Semelka RC, Shoenut JP, Greenberg HM, Bow EJ: Detection of acute and treated lesions of hepatosplenic candidiasis: Comparison of dynamic contrast-enhanced CT and MR imaging. J Magn Reson Imaging 2:341-345, 1992
97. Semelka RC, Kelekis NL, Sallah S, et al: Hepatosplenic fungal disease: Diagnostic accuracy and spectrum of appearances on MR imaging. AJR 169:1311-1316, 1997
98. Lamminen AE, Anttila VJ, Bondestam S, Ruutu T, Ruutu PJ: Infectious liver foci in leukemia: Comparison of short-inversion-time inversion-recovery, T1-weighted spin-echo, and dynamic gadolinium-enhanced MR imaging. Radiology 191:539-543, 1994
99. Cho JS, Kim EE, Varma DG, Wallace S: MR imaging of hepatosplenic candidiasis superimposed on hemochromatosis. J Comput Assist Tomogr 14:774-776, 1990
100. Anttila VJ, Lamminen AE, Bondestam S, et al: Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia. Eur J Haematol 56:82-87, 1996
101. Kelekis NL, Semelka RC, Jeon HJ, et al: Dark ring sign: Finding in patients with fungal liver lesions and transfusional hemosiderosis undergoing treatment with antifungal antibiotics. Magn Reson Imaging 14:615-618, 1996
102. Grunebaum M, Ziv N, Kaplinsky C, et al: Liver candidiasis. The various sonographic patterns in the immunocompromised child. Pediatr Radiol 21:497-500, 1991
103. Pastakia B, Shawker TH, Thaler M, et al: Hepatosplenic candidiasis: Wheels within wheels. Radiology 166:417-421, 1988
104. Mathieu D, Vilgrain V, Mahfouz A, et al: Benign liver tumors. Magn Reson Imaging Clin North Am 5:255-288, 1997
105. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194-1200, 1985
106. Craig JR, Peters RL, Edmondson HA: Tumors of the liver and intrahepatic bile ducts. Washington, DC, Armed Forces Institute of Pathology, 1989, vol Fasc 26, 2nd ser
107. Buetow PC, Pantongrag-Brown L, Buck JL, et al: Focal nodular hyperplasia of the liver: Radiologie-pathologie correlation. Radiographies 16:369-388, 1996
108. Di Stasi M, Caturelli E, De Sio I, et al: Natural history of focal nodular hyperplasia of the liver: An ultrasound study. J Clin Ultrasound 24:345-350, 1996
109. Sadowski DC, Lee SS, Wanless IR, et al: Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology 21:970-975, 1995
110. Lee MJ, Saini S, Hamm B, et al: Focal nodular hyperplasia of the liver: MR findings in 35 proved cases. AJR Am J Roentgenol 156:317-320, 1991
111. Padovani B, Marie JF, Sedat J, et al: [1,5 Tesla MRI in focal nodular hyperplasia. Review of the literature apropos of 7 cases]. J Radiol 75:111-116, 1994
112. Haggar AM, Bree RL: Hepatic focal nodular hyperplasia: MR imaging at 1.0 and 1.5 T. J Magn Reson Imaging 2:85-88, 1992
113. Mitchell DG, Palazzo J, Hann HW, et al: Hepatocellular tumors with high signal on T1-weighted MR images: Chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15:762-769, 1991
114. Bazzocchi M, Macorig D, Cecconi P, Gozzi G: [The imaging diagnosis of hepatic focal nodular hyperplasia]. Radiol Med (Torino) 82:805-813, 1991
115. Mathieu D, Rahmouni A, Anglade MC, et al: Focal nodular hyperplasia of the liver: Assessment with contrast-enhanced TurboFLASH MR imaging. Radiology 180:25-30, 1991
116. Rummeny E, Weissleder R, Sironi S, et al: Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology 171:323-326, 1989
117. Shamsi K, De Schepper A, Degryse H, Deckers F: Focal nodular hyperplasia of the liver: Radiologie findings. Abdom Imaging 18:32-38, 1993
118. Vilgrain V, Flejou JF, Arrive L, et al: Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699-703, 1992
119. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ: Hypervascular liver lesions: Differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 186:133-138, 1993
120. Soyer P, Dufresne AC, Somveille E, Scherrer A: Focal nodular hyperplasia of the liver: Assessment of hemodynamic and angioarchitectural patterns with gadolinium chelateenhanced 3D spoiled gradient-recalled MRI and maximum intensity projection reformatted images. J Comput Assist Tomogr 20:898-904, 1996
121. Vogl TJ, Hammerstingl R, Schwarz W, et al: Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31:696-708, 1996
122. Vogl TJ, Hammerstingl R, Schwarz W, et al: Superparamagnetic iron oxide - enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881-887, 1996
123. Denys A, Arrive L, Servois V, et al: Hepatic tumors: Detection and characterization at 1-T MR imaging enhanced with AMI-25 [see comments]. Radiology 193:665-669, 1994
124. Grandin CB, Van Beers BE, Pauwels S, et al: Ferumoxides and Tc-99m sulfur colloid: Comparison of the tumor-to-liver uptake in focal nodular hyperplasia. J Magn Reson Imaging 7:125-129, 1997
125. Grandin C, Van Beers BE, Robert A, et al: Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 19:412-418, 1995
126. Mattison GR, Glazer GM, Quint LE, et al: MR imaging of hepatic focal nodular hyperplasia: Characterization and distinction from primary malignant hepatic tumors. AJR Am J Roentgenol 148:711-715, 1987
127. Paulson EK, McClellan JS, Washington K, et al: Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR 163:113-116, 1994
128. Baum JK, Holtz F, Bookstein JJ, Klein EW: Possible association between benign hepatomas and oral contraceptives. Lancet 2:926-929, 1973
129. Rooks JB, Ory HW, Ishak KG, et al: Epidemiology of hepatocellular adenoma: The role of oral contraceptive use. JAMA 242:644-648, 1979
130. Rosenberg L: The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 43:643-652, 1991
131. Daldrup HE, Reimer P, Rummeny EJ, et al: [The regression of a hepatocellular adenoma after the withdrawal of hormonal contraception]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 163:449-451, 1995
132. Kawakatsu M, Vilgrain V, Erlinger S, Nahun H: Disappearance of liver cell adenoma: CT and MR Imaging. Abdom Imaging 22:274-276, 1997
133. Labrune P, Trioche P, Duvaltier I, et al: Hepatocellular adenomas in glycogen storage disease type I and III: A series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24:276-279, 1997
134. Leese T, Farges O, Bismuth H: Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 208:558-564, 1988
135. Gordon SC, Reddy KR, Livingstone AS, et al: Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 105:547-549, 1986
136. Gyorffy EJ, Bredfeldt JE, Black WC: Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med 110:489-490, 1989
137. Mathieu D, Paret M, Mahfouz AE, et al: Hyperintense benign liver lesions on spin-echo T1-weighted MR images: Pathologic correlations. Abdom Imaging 22:410-417, 1997
138. Arrive L, Flejou JF, Vilgrain V, et al: Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507-512, 1994
139. Chung KY, Mayo-Smith WW, Saini S, et al: Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 165:303-308, 1995
140. Hayman LA, Taber KH, Ford JJ, Bryan RN: Mechanisms of MR signal alteration by acute intracerebral blood: Old concepts and new theories. AJNR Am J Neuroradiol 12:899-907, 1991
141. Baker ME, Pelley R: Hepatic metastases: Basic principles and implications for radiologists. Radiology 197:329-337, 1995
142. Mahfouz AE, Hamm B, Mathieu D: Imaging of metastases to the liver. Eur Radiol 6:607-614, 1996
143. de Brauw LM, van de Velde CJ, Bouwhuis-Hoogerwerf ML, Zwaveling A: Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 34:81-86, 1987
144. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 77:1241-1246, 1990
145. Ballantyne GH, Quin J: Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252-4266, 1993
146. Bozzetti F, Cozzaglio L, Boracchi P, et al: Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. Eur J Surg Oncol 19:162-167, 1993
147. Wagner JS, Adson MA, Van Heerden JA, et al: The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502-508, 1984
148. VanderMeer TJ, Callery MP, Meyers WC: The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma. Hematol Oncol Clin North Am 11:759-777, 1997
149. Cady B, Stone MD, McDermott WV, Jr., et al: Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 127:561-568; discussion 568-569, 1992
150. Rosen CB, Nagorney DM, Taswell HF, et al: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493-504; discussion 504-495, 1992
151. van Ooijen B, Wiggers T, Meijer S, et al: Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study. Cancer 70:28-34, 1992
152. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13-29, 1991
153. Anonymous: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer [see comments]. J Natl Cancer Inst 88:252-258, 1996
154. Rougier P, Laplanche A, Huguier M, et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial [see comments]. J Clin Oncol 10:1112-1118, 1992
155. Soulen MC: Chemoembolization of hepatic malignancies. Oncology (Huntingt) 8:77-84; discussion 84, 89-90 passim, 1994
156. Outwater E, Tomaszewski JE, Daly JM, Kressel HY: Hepatic colorectal metastases: Correlation of MR imaging and pathologic appearance. Radiology 180:327-332, 1991
157. Ito K, Mitchell DG, Outwater EK, et al: Hepatic leisons: Discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 204:729-737, 1997
158. Goldberg MA, Hahn PF, Saini S, et al: Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol 160:1011-1017, 1993
159. Larson RE, Semelka RC, Bagley AS, et al: Hypervascular malignant liver lesions: Comparison of various MR imaging pulse sequences and dynamic CT. Radiology 192:393-399, 1994
160. Hamm B, Mahfouz AE, Taupitz M, et al: Liver metastases: Improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 202:677-682, 1997
161. Peterson MS, Baron RL, Murakami T: Hepatic malignancies: Usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 201:337-345, 1996
162. Soyer P, Laissy JP, Sibert A, Menu Y: Dynamic gadolinium-DOTA-enhanced MR imaging at 1.0 T. Value in the differentiation of hepatic tumors. Clin Imaging 20:118-125, 1996
163. Van Beers B, Demeure R, Pringot J, et al: Dynamic spin-echo imaging with Gd-DTPA: Value in the differentiation of hepatic tumors. AJR Am J Roentgenol 154:515-519, 1990
164. Mahfouz AE, Hamm B, Wolf KJ: Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions [see comments]. Radiology 190:49-52, 1994
165. Hamm B, Thoeni RF, Gould RG, et al: Focal liver lesions: Characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 190:417-423, 1994
166. Semelka RC, Schlund JF, Molina PL, et al: Malignant liver lesions: Comparison of spiral Ct arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging 6:39-43, 1996
167. van Ooijen B, Oudkerk M, Schmitz PIM, Wiggers T: Detection of liver metastases from colorectal carcinoma: Is there a place for routine computed tomography arteriography? Surgery 119:511-516, 1996
168. Seneterre E, Taourel P, Bouvier Y, et al: Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography [see comments]. Radiology 200:785-792, 1996
169. Ros PR, Freeny PC, Harms SE, et al: Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481-488, 1995
170. Reimer P, Rummeny EJ, Daldrup HE, et al: Clinical results with Resovist: A phase 2 clinical trial. Radiology 195:489-496, 1995
171. Winter TC, Freeny PC, Nghiem HV, et al: MR imaging with i.v. superparamagnetic iron oxide: Efficacy in the detection of focal hepatic lesions. AJR Am J Roentgenol 161:1191-1198, 1993
172. Bellin MF, Zaim S, Auberton E, et al: Liver metastases: Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193:657-663, 1994
173. Fretz CJ, Stark DD, Metz CE, et al: Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol 155:763-770, 1990
174. Hagspiel KD, Neidl KFW, Eichenberger AC, et al: Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, introperative US, and percutaneous US. Radiology 196:471-478, 1995
175. Blakeborough A, Ward J, Wilson D, et al: Hepatic lesion detection at MR imaging: A comparitive study with four sequences. Radiology 203:759-765, 1997
176. Semelka RC, Kelekis N: Liver, in Semelka RC, Ascher SM, Reinhold C (eds): MRI of the Abdomen and Pelvis. New York, NY, Wiley-Liss, 1997, pp 19-136
177. Dudiak KM: Abdominal case of the day. Hepatocellular carcinoma in a patient with primary hemochromatosis. AJR Am J Roentgenol 160:1325-1327, 1993
178. Deugnier YM, Guyader D, Crantock L, et al: Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 104:228-234, 1993
179. Guyader D, Gandon Y: MR of hepatocellular carcinoma in idiopathic hemochromatosis. AJR Am J Roentgenol 151:833, 1988
180. Buetow PC, Midkiff RB: Primary malignant neoplasms in the adult. Magn Reson Imaging Clin North Am 5:289-318, 1997
181. Anonymous: Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22:983-993, 1995
182. Wu TT, Boitnott J: Dysplastic nodules: A new term for premalignant hepatic nodular lesions [editorial; comment]. Radiology 201:21-22, 1996
183. Martin J, Sentis M, Zidan A, et al: Fatty metamorphosis of hepatocellular carcinoma: Detection with chemical shift gradient-echo MR imaging. Radiology 195:125-130, 1995
184. Kelekis NL, Semelka RC, Woosley JT: Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 6:291-294, 1996
185. Kadoya M, Matsui O, Takashima T, Nonomura A: Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings. Radiology 183:819-825, 1992
186. Honda H, Onitsuka H, Kanazawa Y, et al: MR imaging of hepatocellular carcinoma. Correlation of metal content and signal intensity. Acta Radiol 36:163-167, 1995
187. Honda H, Kaneko K, Kanazawa Y, et al: MR imaging of hepatocellular carcinomas: Effect of Cu and Fe contents on signal intensity. Abdom Imaging 22:60-66, 1997
188. Yoshikawa J, Matsui O, Takashima T, et al: Fatty metamorphosis in hepatocellular carcinoma: Radiologic features in 10 cases. AJR Am J Roentgenol 151:717-720, 1988
189. Kitagawa K, Matsui O, Kadoya M, et al: Hepatocellular carcinomas with excessive copper accumulation: CT and MR findings. Radiology 180:623-628, 1991
190. Ebara M, Watanabe S, Kita K, et al: MR imaging of small hepatocellular carcinoma: Effect of intratumoral copper content on signal intensity. Radiology 180:617-621, 1991
191. Matsuzaki K, Sano N, Hashiguchi N, et al: Influence of copper on MRI of hepatocellular carcinoma. J Magn Reson Imaging 7:478-481, 1997
192. Itoh K, Nishimura K, Togashi K, et al: Hepatocellular carcinoma: MR imaging. Radiology 164:21-25, 1987
193. Hirai K, Aoki Y, Majima Y, et al: Magnetic resonance imaging of small hepatocellular carcinoma. Am J Gastroenterol 86:205-209, 1991
194. Muramatsu Y, Nawano S, Takayasu K, et al: Early hepatocellular carcinoma: MR imaging. Radiology 181:209-213, 1991
195. Matsui O, Kadoya M, Kameyama T, et al: Adenomatous hyperplastic nodules in the cirrhotic liver: Differentiation from hepatocellular carcinoma with MR imaging. Radiology 173:123-126, 1989
196. Yamashita Y, Fan ZM, Yamamoto H, et al: Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: Correlation with histopathologic findings. J Magn Reson Imaging 4:83-90, 1994
197. Inoue E, Kuroda C, Narumi Y, et al: Magnetic resonance imaging-histologic correlation of small hepatocellular carcinomas adenomatous hyperplasias. Invest Radiol 28:691-697, 1993
198. Inoue E, Kuroda C, Fujita M, et al: MR features of various histological grades of small hepatocellular carcinoma. J Comput Assist Tomogr 17:75-79, 1993
199. Itai Y, Ohnishi S, Ohtomo K, et al: Regenerating nodules of liver cirrhosis: MR imaging. Radiology 165:419-423, 1987
200. Earls JP, Theise ND, Weinreb JC, et al: Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation [see comments]. Radiology 201:207-214, 1996
201. Matsui O, Kadoya M, Kameyama T, et al: Benign and malignant nodules in cirrhotic livers: Distinction based on blood supply. Radiology 178:493-497, 1991
202. Fujita T, Honjo K, Ito K, et al: High-resolution dynamic MR imaging of hepatocellular carcinoma with a phased array body coil. Radiographies 17:315-331, 1997
203. Itoh K, Honjo K, Honma Y, et al: [Evaluation of breath-hold multislice dynamic MRI of hepatocellular carcinomas]. Nippon Igaku Hoshasen Gakkai Zasshi 52:399-401, 1992
204. Kim T, Murakami T, Oi H, et al: Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 19:948-954, 1995
205. Lencioni R, Mascalchi M, Caramella D, Bartolozzi C: Small hepatocellular carcinoma: Differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 21:41-48, 1996
206. Oi H, Murakami T, Kim T, et al: Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR Am J Roentgenol 166:369-374, 1996
207. Yamashita Y, Mitsuzaki K, Yi T, et al: Small hepatocellular carcinoma in patients with chronic liver damage: Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200:79-84, 1996
208. Fukuya T, Honda H, Maeda T, et al: Well-differentiated hepatocellular carcinoma: Isointense to liver parenchyma on superparamagnetic iron oxide-enhanced MR. Radiat Med 13:35-37, 1995
209. Van Beers B, Trigaux JP, Grandin C, et al: Regenerative nodules in hepatic cirrhosis. Value of gradient-echo MR imaging with a surface coil. Acta Radiol 33:245-250, 1992
210. Ohtomo K, Itai Y, Ohtomo Y, et al: Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR Am J Roentgenol 154:505-507, 1990
211. Koslow SA, Davis PL, DeMarino GB, et al: Hyperintense cirrhotic nodules on MRI. Gastrointest Radiol 16:339-341, 1991
212. Murakami T, Marukawa T, Kuroda C, et al: [Siderotic regenerating nodules in liver cirrhosis-evaluation by gradient echo (FLASH) imaging 1.5T]. Nippon Igaku Hoshasen Gakkai Zasshi 49:1427-1429, 1989
213. Murakami T, Kuroda C, Marukawa T, et al: Regenerating nodules in hepatic cirrhosis: MR findings with pathologic correlation. AJR Am J Roentgenol 155:1227-1231, 1990
214. Murakami T, Nakamura II, Kuroda C, et al: Siderotic nodules in hepatic cirrhosis disappearing after biliary hemorrhage: MR imaging. J Comput Assist Tomogr 15:1039-1041, 1991
215. Murakami T, Nakamura H, Hori S, et al: CT and MRI of siderotic regenerating nodules in hepatic cirrhosis. J Comput Assist Tomogr 16:578-582, 1992
216. Terada T, Nakanuma Y: Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 10:851-854, 1989
217. Terada T, Nakanuma Y: Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions. Arch Pathol Lab Med 113:916-920, 1989
218. Terada T, Kadoya M, Nakanuma Y, Matsui O: Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 65:1994-2000, 1990
219. Mitchell DG, Rubin R, Siegelman ES, et al: Hepatocellular carcinoma within siderotic regenerative nodules: Appearance as a nodule within a nodule on MR images. Radiology 178:101-103, 1991
220. Sadek AG, Mitchell DG, Siegelman ES, et al: Early hepatocellular carcinoma that develops within macroregenerative nodules: Growth rate depicted at serial MR imaging. Radiology 195:753-756, 1995
221. Corrigan K, Semelka RC: Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 20:122-125, 1995
222. Francis IR, Agha FP, Thompson NW, Keren DF: Fibrolamellar hepatocarcinoma: Clinical, radiologie, and pathologic features. Gastrointest Radiol 11:67-72, 1986
223. Dubois J, Garel L, Russo P, Jequier S: Pediatric case of the day. Fibrolamellar hepatocellular carcinoma. Radiographies 13:691-692, 1993
224. Brandt DJ, Johnson CD, Stephens DH, Weiland LH: Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 151:295-299, 1988
225. Friedman AC, Lichtenstein JE, Goodman Z, et al: Fibrolamellar hepatocellular carcinoma. Radiology 157:583-587, 1985
226. Stevens WR, Johnson CD, Stephens DH, Nagorney DM: Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. AJR Am J Roentgenol 164:1153-1158, 1995
227. Caseiro-Alves F, Zins M, Mahfouz AE, et al: Calcification in focal nodular hyperplasia: A new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 198:889-892, 1996
228. Titelbaum DS, Hatabu H, Schiebler ML, et al: Fibrolamellar hepatocellular carcinoma: MR appearance. J Comput Assist Tomogr 12:588-591, 1988
229. Hamrick-Turner JE, Shipkey FH, Cranston PE: Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr 18:301-304, 1994
230. Saul SH: Masses of the liver, in Sternberg SS (ed): Diagnostic Surgical Pathology, 2nd ed. New York, NY, Raven Press, 1994, pp 1543-1545
231. Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW: Intrahepatic cholangiocarcinoma: Radiologie-pathologic correlation. Radiology 167:689-693, 1988
232. Broome U, Olsson R, Loof L, et al: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38:610-615, 1996
233. Mitchell SA, Chapman RW: Review article: The management of primary sclerosing cholangitis. Aliment Pharmacol Ther 11:33-43, 1997
234. Broome U, Lofberg R, Veress B, Eriksson LS: Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential [see comments]. Hepatology 22: 1404-1408, 1995
235. Goss JA, Shackleton CR, Farmer DG, et al: Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225:472-481; discussion 481-473, 1997
236. Knechtle SJ, D'Alessandro AM, Harms BA, et al: Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 118:615-619; discussion 619-620, 1995
237. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation with the porta hepatis. Am J Med 38:241-256, 1965
238. Kuszyk BS, Soyer P, Bluemke DA, Fishman EK: Intrahepatic cholangiocarcinoma: The role of imaging in detection and staging. Crit Rev Diagn Imaging 38:59-88, 1997
239. Baer HU, Stain SC, Dennison AR, et al: Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 217:20-27, 1993
240. Alden ME, Waterman FM, Topham AK, et al: Cholangiocarcinoma: Clinical significance of tumor location along the extrahepatic bile duct. Radiology 197:511-516, 1995
241. Eschelman DJ, Shapiro MJ, Bonn J, et al: Malignant biliary duct obstruction: Long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology 200:717-724, 1996
242. Soyer P, Bluemke DA, Sibert A, Laissy JP: MR imaging of intrahepatic cholangiocarcinoma. Abdom Imaging 20:126-130, 1995
243. Fan ZM, Yamashita Y, Harada M, et al: Intrahepatic cholangiocarcinoma: Spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 161:313-317, 1993
244. Hashimoto T, Nakamura H, Hori S, et al: MR imaging of mixed hepatocellular and cholangiocellular carcinoma. Abdom Imaging 19:430-432, 1994
245. Vilgrain V, Van Beers BE, Flejou JF, et al: Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59-65, 1997
246. Gautier AL, Vilgrain V, Flejou JF, et al: [Imaging of peripheral cholangiocarcinoma. Comparison with pathological anatomy]. Gastroenterol Clin Biol 20:139-145, 1996
247. Hamrick-Turner J, Abbitt PL, Ros PR: Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158:77-79, 1992
248. Soyer P, Bluemke DA, Reichle R, et al: Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR Am J Roentgenol 165:1427-1431, 1995
249. Lacomis JM, Baron RL, Oliver JHr, et al: Cholangiocarcinoma: Delayed CT contrast enhancement patterns. Radiology 203:98-104, 1997
250. Murakami T, Nakamura H, Tsuda K, et al: Contrastenhanced MR imaging of intrahepatic cholangiocarcinoma: Pathologic correlation study. J Magn Reson Imaging 5:165-170, 1995
251. Guthrie JA, Ward J, Robinson PJ: Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 201:347-351, 1996
252. Carr DH, Hadjis NS, Banks LM, et al: Computed tomography of hilar cholangiocarcinoma: A new sign. AJR Am J Roentgenol 145:53-56, 1985
253. Takayasu K, Muramatsu Y, Shima Y, et al: Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 160:389-393, 1986
254. Hann LE, Getrajdman GI, Brown KT, et al: Hepatic lobar atrophy: Association with ipsilateral portal vein obstruction. AJR Am J Roentgenol 167:1017-1021, 1996
255. Hadjis NS, Adam A, Blenkharn I, et al: Primary sclerosing cholangitis associated with liver atrophy. Am J Surg 158:43-47, 1989
256. Siegelman ES, Outwater EK, Piccoli CW, et al: MRI of benign and malignant hepatic lobar atrophy. Clin Imaging 21:43-50, 1997
257. Matsui O, Kadoya M, Takashima T, et al: Intrahepatic periportal abnormal intensity on MR images: An indication of various hepatobiliary diseases. Radiology 171:335-338, 1989
258. Kessler A, Mitchell DG, Israel HL, Goldberg BB: Hepatic and splenic sarcoidosis: Ultrasound and MR imaging. Abdom Imaging 18:159-163, 1993
259. Warshauer DM, Semelka RC, Ascher SM: Nodular sarcoidosis of the liver and spleen: Appearance on MR images. J Magn Reson Imaging 4:553-557, 1994
260. Ernst O, Asselah T, Talbodec N, et al: MR cholangiopan-creatography: A promising new tool for diagnosing primary sclerosing cholangitis [letter; comment]. AJR Am J Roentgenol 168:1115-1116, 1997
261. Mergo PJ, Ros PR, Buetow PC, Buck JL: Diffuse disease of the liver: Radiologic-pathologic correlation. Radiographics 14:1291-1307, 1994
262. Rofsky NM, Fleishaker H: CT and MRI of diffuse liver disease. Semin Ultrasound CT MRI 16:16-33, 1995
263. Brown JJ, Naylor MJ, Yagan N: Imaging of hepatic cirrhosis. Radiology 202:1-16, 1997
264. Mitchell DG, Lovett KE, Hann HW, et al: Cirrhosis: Multiobserver analysis of hepatic MR imaging findings in a heterogeneous population. J Magn Reson Imaging 3:313-321, 1993
265. Ohtomo K: Cirrhosis and premalignant nodules. Magn Reson Imaging Clin North Am 5:331-346, 1997
266. Ito K, Mitchell DG, Hann HWL, et al: Compensated cirrhosis due to viral hepatitis: Using MR imaging to predict clinical progression. AJR 169:801-805, 1997
267. Mitchell DG, Nazarian LN: Hepatic vascular diseases: CT and MRI. Semin US CT MRI 16:49-68, 1995
268. Spritzer CE: Vascular diseases and MR angiography of the liver. Magn Reson Imaging Clin North Am 5:377-395, 1997
269. Ohtomo K, Baron RL, Dodd Godd, et al: Confluent hepatic fibrosis in advanced cirrhosis: Evaluation with MR imaging. Radiology 189:871-874, 1993
270. Khullar S, Bjorkman DJ, Tolman KG: Clinical perspective: The importance of imaging in diffuse liver disease and hepatic vascular disorders. Semin US CT MRI 16:2-7, 1995
271. Van Steenbergen W, Lanckmans S: Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord 19:827-36, 1995
272. Clain DJ, Lefkowitch JH: Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 16:239-252, 1987
273. Palmer M, Schaffner F: Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99:1408-1413, 1990
274. Teli MR, James OF, Burt AD, et al: The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology 22:1714-1719, 1995
275. Wehrli FW, Perkins TG, Shimakawa A, Roberts F: Chemical shift-induced amplitude modulations in images obtained with gradient refocusing. Magn Reson Imaging 5:157-158, 1987
276. Outwater EK: Adrenal masses: Capabilities of MRI for simple characterization. Applied Radiol 26:27-31, 1997
277. Kreft BP, Tanimoto A, Baba Y, et al: Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging 2:463-471, 1992
278. Levenson H, Greensite F, Hoefs J, et al: Fatty infiltration of the liver: Quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 156:307-312, 1991
279. Mitchell DG, Kim I, Chang TS, et al: Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 26:1041-1052, 1991
280. Mitchell DG: Chemical shift magnetic resonance imaging: Applications in the abdomen and pelvis. Top Magn Reson Imaging 4:46-63, 1992
281. Birnbaum BA, Weinreb JC, Fernandez MP, et al: Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings. Clin Imaging 18:21-27, 1994
282. Matsui O, Takahashi S, Kadoya M, et al: Pseudolesion in segment TV of the liver at CT during arterial portography: Correlation with aberrant gastric venous drainage. Radiology 193:31-35, 1994
283. Matsui O, Kadoya M, Yoshikawa J, et al: Aberrant gastric venous drainage in cirrhotic livers: Imaging findings in focal areas of liver parenchyma [see comments]. Radiology 197:345-349, 1995
284. Matsui O, Kadoya M, Takahashi S, et al: Focal sparing of segment IV in fatty livers shown by sonography and CT: Correlation with aberrant gastric venous drainage. AJR Am J Roentgenol 164:1137-1140, 1995
285. Kawamori Y, Matsui O, Takahashi S, et al: Focal hepatic fatty infiltration in the posterior edge of the medial segment associated with aberrant gastric venous drainage: CT, US, and MR findings. J Comput Assist Tomogr 20:356-359, 1996
286. Soyer P, Devine N, Somveille E, et al: Hepatic pseudolesion around the falciform liagment: Prevalence on CT examination. Abdom Imaging 21:324-328, 1996
287. Lipman JC, Stomper PC, Kaplan WD, Tumeh SS: Detection of hepatic metastases in diffuse fatty infiltration by CT: The complementary role of imaging. Clin Nucl Med 13:602-605, 1988
288. Onaya H, Itai Y, Kurosaki Y, et al: Metastatic tumors in irregular fatty liver mimicking focal sparing. Radiat Med 12:69-73, 1994
289. Llauger J, Perez C, Coscojuela P, et al: Hepatic metastases: False-negative CT portography in cases of fatty infiltration. J Comput Assist Tomogr 15:320-322, 1991
290. Steiner W, Scheidler J, Kohz P, et al: [Ct-portography in diffuse liver steatosis. Potential for a false-negative assessment]. Radiologe 34:84-87, 1994
291. Feder JN, Gnirke A, Thomas W, et al: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [see comments]. Nat Genet 13:399-408, 1996
292. MacLaren GD, Muir WA, Kcllermeyer RW: Iron overload disorders: Natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci 19:205-266, 1984
293. MacDonald RA, Endo H, Pechet GS: Studies of experimental hemochromatosis: Disorder of the reticuloendothelial system and excess iron. Arch Pathol 85:366, 1968
294. Rouault TA: Hereditary hemochromatosis [clinical conference]. JAMA 269:3152-3154, 1993
295. Siegelman ES, Mitchell DG, Semelka RC: Abdominal iron deposition: Metabolism, MR findings, and clinical importance. Radiology 199:13-22, 1996
296. Siegelman ES, Mitchell DG, Outwater E, et al: Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients. Radiology 188:637-641, 1993
297. Siegelman ES, Mitchell DG, Rubin R, et al: Parenchymal versus reticuloendothelial iron overload in the liver: Distinction with MR imaging [see comments]. Radiology 179:361-366, 1991
298. Adams PC, Speechley M, Kertesz AE: Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 101:368-372, 1991
299. Niederau C, Fischer R, Sonnenberg A, et al: Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256-1262, 1985
300. Jandl JH: Blood: Textbook of Hematology. Boston, MA, Little, Brown, 1987
301. Powell LW, Bassett ML, Halliday JW: Hemochromatosis: 1980 update. Gastroenterology 78:374-381, 1980
302. Brittenham GM, Griffith PM, Nienhuis AW, et al: Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567-573, 1994
303. Zuppinger K, Molinari B, Hirt A, et al: Increased risk of diabetes mellitus in beta-thalassemia major due to iron overload. Helv Paediatr Acta 34:197-207, 1979
304. Rofsky NM, Weinreb JC, Ambrosino MM, et al: Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 20:230-235, 1996
305. Siegelman ES: MR imaging of diffuse liver disease. Magn Reson Imaging Clin North Am 5:347-365, 1997
306. Silverman SG, Hillstrom MM, Doyle CJ, et al: Thrombophlebitic retroperitoneal collateral veins mimicking lymphadenopathy: MR and CT appearance. Abdom Imaging 20:474-476, 1995
307. Blattler W, Krayenbuhl C: [Spinal canal stenosis syndrome by venous collateralization of an inferior cava thrombosis]. Phlebologie 46:411-414; discussion 415, 1993
308. Singson RD, Dee G, Quader MA: Case report 265. Scalloping and destruction of pedicles of lumbar vertebral bodies on the right side secondary to venous collaterals, associated with thrombosis of the inferior vena cava. Skeletal Radiol 11:293-295, 1984
309. Low RN, Barone RM, Lacey C, et al: Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513-520, 1997
310. Low RN, Sigeti JS: MR imaging of peritoneal disease: Comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR Am J Roentgenol 163:1131-1140, 1994
311. Tsushima Y, Dean PB: Characterization of adrenal masses with chemical shift MR imaging: How to select echo times [letter]. Radiology 195:285-286, 1995
312. Tartaglino LM, Flanders AE, Vinitski S, Friedman DP: Metallic artifacts on MR images of the postoperative spine: Reduction with fast spin-echo techniques. Radiology 190:565-569, 1994